PDK1 and hepatocellular carcinoma: This present study as we depicted in our schematic abstract (Figure 6), demonstrated that aberrantly expressed PDK1 independently drives PI3K/AKT/mTOR oncogenic signaling, characterizes poorly differentiated cells, activates ALDH1 and is associated with the desensitization of aggressive hepatocellular carcinoma cells to radiotherapy.